We are live on ! Find out more
PEPLW

PepperLime Health Acquisition Corporation Warrrant
PEPLW

Delisted

PEPLW was delisted on the 21st of March, 2024.

Back to rankings

23 hedge funds and large institutions have $5.76M invested in PepperLime Health Acquisition Corporation Warrrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

10% more funds holding

Funds holding: 21 → 23 (+2)

9% less capital invested

Capital invested by funds: $6.35M → $5.76M (-$593K)

Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
2
Closed
1
Calls
$2.23M
Puts
–
Net Calls
+$2.23M
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
+$50.6K
2
MF
Magnetar Financial
Illinois
+$47.5K
3
MP
Mangrove Partners
Connecticut
+$2.19K
4
EFI
EHP Funds Inc
Canada
+$1.7K
5
CAC
Cowen and Company
New York
+$362

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$1.06K
2
CS
Clear Street
New York
-$14
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$5.14M – – –
MP
2
Mangrove Partners
Connecticut
$151K +$2.19K +15,129 New
EAM
3
Empery Asset Management
New York
$59K – – –
HCM
4
Highbridge Capital Management
New York
$54K – – –
SCM
5
Shaolin Capital Management
Florida
$50K – – –
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$42K – – –
EFI
7
EHP Funds Inc
Canada
$40K +$1.7K +11,772 +2%
RCM
8
Rivernorth Capital Management
Florida
$37K – – –
Calamos Advisors
9
Calamos Advisors
Illinois
$28K +$50.6K +350,000 New
ACM
10
Altium Capital Management
New York
$27K – – –
MF
11
Magnetar Financial
Illinois
$25K +$47.5K +328,600 New
AA
12
AQR Arbitrage
Connecticut
$24K – – –
PC
13
Periscope Capital
Ontario, Canada
$19K – – –
SCM
14
Saba Capital Management
New York
$11K – – –
CAC
15
Cowen and Company
New York
$10K +$362 +2,507 +2%
RA
16
Ramius Advisors
New York
$8K – – –
WAM
17
Wolverine Asset Management
Illinois
$7K – – –
DCM
18
Difesa Capital Management
New York
$6K – – –
PCM
19
Prelude Capital Management
New York
$6K – – –
UOC
20
UBS O'Connor
Illinois
$5K -$1.06K -7,343 -9%
AGM
21
Alpine Global Management
New York
$3K – – –
CS
22
Clear Street
New York
$1K -$14 -100 -0.8%
AA
23
Ancora Advisors
Ohio
$1K – – –
RCM
24
Robinson Capital Management
Michigan
– +$50 +343 +15%

PEPLW Hedge Fund Activity: Q3 2022 in Review

23 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in PepperLime Health Acquisition Corporation Warrrant (PEPLW) for Q3 2022, worth a combined $5.76M — down 9.3% from $6.35M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PEPLW positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $50.6K. The largest seller was UBS O'Connor, cutting an estimated $1.06K.

  • 23 institutional investors held PepperLime Health Acquisition Corporation Warrrant (PEPLW) as of Q3 2022, up from 21 in Q2 2022.
  • Funds reported $5.76M of PepperLime Health Acquisition Corporation Warrrant stock for Q3 2022, down 9.3% quarter-over-quarter.
  • 3 funds opened new PepperLime Health Acquisition Corporation Warrrant positions in Q3 2022 and 1 closed out, a net change of +2 holders.
  • The largest PepperLime Health Acquisition Corporation Warrrant buyer in Q3 2022 was Calamos Advisors, an estimated $50.6K added.
  • The largest PepperLime Health Acquisition Corporation Warrrant seller in Q3 2022 was UBS O'Connor, an estimated $1.06K sold.

Based on aggregated 13F filings for Q3 2022.